Silence Therapeutics SLN
$19.81 +$0.00 (0.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $19.81 0.00%
Open$19.81
Prev close$19.81
Day range$19.80 – $19.83
Volume399.1K
Market cap$1.23B
P/E (TTM)–
Dividend yield–
SLN Stock News
Headlines matching Silence Therapeutics or the SLN ticker, most recent first.
- H.C. Wainwright Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $75
- William Blair Maintains Silence Therapeutics(SLN.US) With Buy Rating
- Chardan Capital Maintains Silence Therapeutics(SLN.US) With Buy Rating
- Silence Therapeutics Expects Offering to Close on or About Aug. 13 SLN
- Morgan Stanley Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $32
- A Quick Look at Today's Ratings for Silence Therapeutics(SLN.US), With a Forecast Between $27 to $75
- Cantor Fitzgerald Initiates Silence Therapeutics(SLN.US) With Buy Rating
- Morgan Stanley Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $25
- Chardan Capital Maintains Silence Therapeutics(SLN.US) With Buy Rating, Cuts Target Price to $27 Negative
- Silence Therapeutics (SLN) Receives a Buy From H.C. Wainwright
- H.C. Wainwright Reaffirms Their Buy Rating on Silence Therapeutics (SLN)
- William Blair Maintains Silence Therapeutics(SLN.US) With Buy Rating, Announces Target Price $5.5
- Goldman Sachs Maintains Silence Therapeutics(SLN.US) With Sell Rating, Maintains Target Price $4
- Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR), Medline, Inc. Class A (MDLN) and Silence Therapeutics (SLN)
- Earnings Flash (SLN) Silence Therapeutics Posts Q3 Net Loss $0.08 a Share, Vs. FactSet Est of $0.08 Loss Negative
No comments yet — be the first to weigh in on SLN.
Sign in to join the discussion.